摘要
目的:建立同时测定复方硝酸异山梨酯胶囊中氢氯噻嗪、卡托普利、阿司匹林、硝酸异山梨酯和尼群地平含量的方法。方法:采用反相高效液相色谱。紫外波长切换法。色谱柱为YMC—PackProC。。柱,流动相为乙腈-水(用磷酸调节pH至2.5,进行梯度洗脱),流速为1.0ml/min,柱温为40℃,进样量为5μl,检测波长0~5.6min为271nm,〉5.6~8.0min为215nm,〉8.0~12.0min为276nm,〉12.0~17.0min为303nm,〉17.0~23.0min为230nm,〉23.0~35.0min为235nm。结果:氢氯噻嗪、卡托普利、阿司匹林、硝酸异山梨酯、尼群地平检测质量浓度分别在7.97~510.38、16.09~1030.02、16.42~1050.60、5.10~326.20、8.48~542.60μg/ml范围内与峰面积积分值呈良好的线性关系(r=0.9997、0.9997、0.9995、0.9996、0.9995);精密度、稳定性、重复性试验的RSD≤1.54%;平均加样回收率分别为99.60%、99.30%、99.61%、98.88%、99.89%,RSD分别为0.77%、0.61%、0.41%、0.74%、0.88%(n=6)。结论:该方法简便、快速、准确、重复性好,可用于复方硝酸异山梨酯胶囊的质量控制。
OBJECTIVE: To establish the method for simultaneous determination of hydrochlorothiazide, captopril, aspirin, isosorbide dinitrate and nitrendipine in Compound isosorbide dinitrate capsules. METHODS: RP-HPLC-UV wavelength switching method was adopted. The separation was carried out on a YMC-Pack Pro-C18 column with acetonitrile (mobile phase A)-water (adjusted pH to 2.5 with phosphpric acid, mobile phase B) in a gradient elution mode at the flow rate of 1.0 ml/min. The column temperature was set at 40 ℃ and injection volume was 5 μL. At 0-5.6 min, the detection wavelength was 271 nm. At 5.6-8.0 min, the detection wavelength was 215 nm. At 8.0-12.0 rain, the detection wavelength was 276 nm. At 12.0-17.0 min, the detection wavelength was 303 nm. At 17.0-23.0 min, the detection wavelength was 230 nm. At 23.0-35.0 min, the detection wavelength was 235 nm. RESULTS: The linear ranges of hydroehlorothiazide, captopril, aspirin, isosorbide dinitrate and nitrendipine were 7.97-510.38 μg/ml (r=0.999 7), 16.09-1 030.02 μg/ml (r=0.999 7), 16.42-1 050.60 μg/ml (r=0.999 5), 5.10-326.20 μg/ml (r=0.999 6) and 8.48-542.60 μg/ml (r=0.999 5), respectively. RSDs of precision, stability and reproducibility tests were lower than 1.54%. The average recovery rates of them were 101.01% (RSD=0.98% , n=6) , 101.38% (RSD=1.01% , n=6) , 101.39% (RSD= 0.57%, n=6), 102.88%(RSD=1.11%, n=6), 101.83%(RSD=0.98%, n=6). CONCLUSIONS: This method is simple, rapid, accurate and reproducible, which is suitable for the quality control of Compound isosorbide dinitrate capsules.
出处
《中国药房》
CAS
CSCD
2013年第44期4210-4212,共3页
China Pharmacy